× Medicines Discovery Catapult

Liverpool ChiroChem’s (LCC) specialist products can be used as building blocks, fragments and screening compounds to enable small molecule drug discovery. Their chemical technologies provide efficient access to novel chiral building blocks to allow facile access to new chemical space for hit identification and desirable pharmacokinetic properties for effective lead optimisation. LCC’s proprietary products are ideally suited for DNA-encoded library synthesis and Fragment Based Lead Discovery, which many medicinal chemists consider to be the two leading areas of modern-day drug discovery.

Liverpool ChiroChem are a member of our CRO Network, part of our Virtual R&D offering. You can find out more about them on their website.

Liverpool ChiroChem logo